Development and validation of a prediction model to assess the probability of tuberculous pleural effusion in patients with unexplained pleural effusion.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 07 2023
05 07 2023
Historique:
received:
18
12
2022
accepted:
01
07
2023
medline:
7
7
2023
pubmed:
6
7
2023
entrez:
5
7
2023
Statut:
epublish
Résumé
Differentiating tuberculous pleural effusion (TPE) from non-tuberculosis pleural effusion remains a challenge in clinical practice. This study aimed to develop and externally validate a novel prediction model using the peripheral blood tuberculous infection of T cells spot test (T-SPOT.TB) to assess the probability of TPE in patients with unexplained pleural effusion. Patients with pleural effusion and confirmed etiology were included in this study. A retrospective derivation population was used to develop and internally validate the predictive model. Clinical, radiological, and laboratory features were collected, and important predictors were selected using the least absolute shrinkage and selection operator. The prediction model, presented as a web calculator, was developed using multivariable logistic regression. The predictive performance of the model was evaluated for discrimination and calibration and verified in an independent validation population. The developed prediction model included age, positive T-SPOT.TB result, logarithm of the ratio of mononuclear cells to multiple nuclear cells in pleural effusion (lnRMMPE), and adenosine deaminase in pleural effusion ≥ 40 U/L. The model demonstrated good discrimination [with area under the curve of 0.837 and 0.903, respectively] and calibration (with a Brier score of 0.159 and 0.119, respectively) in both the derivation population and the validation population. Using a cutoff value of 60%, the sensitivity and specificity for identifying TPE were 70% and 88%, respectively, in the derivation population, and 77% and 92%, respectively, in the validation population. A novel predictive model based on T-SPOT.TB was developed and externally validated, demonstrating good diagnostic performance in identifying TPE.
Identifiants
pubmed: 37407665
doi: 10.1038/s41598-023-38048-2
pii: 10.1038/s41598-023-38048-2
pmc: PMC10322972
doi:
Substances chimiques
Adenosine Deaminase
EC 3.5.4.4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
10904Informations de copyright
© 2023. The Author(s).
Références
Thorax. 2010 Aug;65 Suppl 2:ii54-60
pubmed: 20696694
Chest. 2007 Apr;131(4):1125-32
pubmed: 17426219
Chest. 2007 Mar;131(3):880-889
pubmed: 17356108
Zhonghua Yi Xue Za Zhi. 2011 Sep 13;91(34):2392-6
pubmed: 22321783
Arch Intern Med. 1984 Feb;144(2):325-8
pubmed: 6696570
Front Med (Lausanne). 2019 Dec 17;6:301
pubmed: 31921874
Lung. 2012 Apr;190(2):239-48
pubmed: 22057296
Int J Tuberc Lung Dis. 2016 Oct;20(10):1386-1391
pubmed: 27725052
Chest. 1996 Jan;109(1):158-62
pubmed: 8549179
Chest. 1997 Sep;112(3):702-6
pubmed: 9315802
Int J Tuberc Lung Dis. 2001 Jul;5(7):673-9
pubmed: 11467374
Braz J Infect Dis. 2007 Feb;11(1):83-8
pubmed: 17625733
J Thorac Dis. 2016 Jul;8(7):E486-94
pubmed: 27499981
Chest. 1991 Apr;99(4):883-6
pubmed: 1901261
Infect Dis (Lond). 2016 Sep;48(9):688-94
pubmed: 27187759
Med Sci Monit. 2003 May;9(5):CR175-80
pubmed: 12761453
Eur Respir J. 2003 Feb;21(2):220-4
pubmed: 12608433
Front Med (Lausanne). 2021 Mar 18;8:639061
pubmed: 33816527
J Clin Invest. 1985 Oct;76(4):1514-21
pubmed: 3902892
PLoS One. 2014 Jan 09;9(1):e85030
pubmed: 24416336
BMC Med Inform Decis Mak. 2011 Oct 14;11:62
pubmed: 21999201
Eur Respir J. 2007 Dec;30(6):1173-9
pubmed: 17715165
Respirology. 2010 Apr;15(3):451-8
pubmed: 20345583
Int J Tuberc Lung Dis. 2020 Nov 1;24(11):1178-1185
pubmed: 33172526